Coherent (COHR) Q1 2027 Earnings Call Transcript

Coherent reported record Q1 revenue of $2.37B, up 56% year over year on a pro forma basis, and non-GAAP EPS of $2.09, up 80%; data center and communications revenue rose 79% to $1.95B. Management forecast Q2 revenue of $2.55B–$2.75B and raised its long-term non-GAAP gross-margin target to above 45% before the end of calendar 2028. The company signed a $20B PhotonLink agreement over five years, with revenue expected to begin ramping in early 2028, amid strong AI-related demand and accelerated capacity investment.

Analysis

The key underwriting issue is not whether AI optics demand is real, but whether Coherent can convert a customer-backed capacity build into durable returns before architectures and sourcing choices shift. The 2028 PhotonLink agreement is strategically meaningful, but its stated value is not equivalent to near-term revenue or guaranteed purchases; verify minimum-volume, cancellation, pricing, and customer-funding terms in filings. Its delayed ramp leaves a gap between today’s capex and that contract’s contribution, while the near-term transceiver and DCI ramps must carry utilization. Customer prepayments on LTAs help share buildout risk, but do not eliminate yield, ramp, or concentration risk.

For competitors, this supports a broader optical-content thesis rather than a simple winner-take-all call: Lumentum Holdings Inc. may benefit from rising laser demand, while Marvell Technology, Inc. has exposure to data-center connectivity but should not be treated as a like-for-like photonics substitute. NVIDIA Corporation’s partnership gives it a potential supply path, while its own deployment pace and architecture choices influence the timing of supplier revenue. Coherent’s vertical integration may improve unit economics as internal InP mix rises, but aggressive capacity additions could amplify downside if customer deployments slip or external supply catches up.

Near term, guidance and margin delivery can support sentiment, but the expectations bar may already be high; absent valuation and consensus data, avoid assigning upside to the headline growth alone. Over 1–3 months, watch sequential gross margin, capex, and order conversion. Over 6–18 months, the thesis depends on 6-inch yields, internal sourcing, and CPO/NPO adoption. The contrarian risk is that management’s market-size and content-per-chip estimates are opportunity framing, not captured revenue. Falsifiers: falling order coverage, weaker transceiver demand, delayed PhotonLink shipments, margin stagnation despite internal capacity, or capex rising without corresponding utilization.

Key Decisions for Investors

• COHR: Favor a staged long on post-earnings weakness rather than chasing a gap higher; size against the possibility that current transceiver growth slows before the 2028 PhotonLink ramp. Reassess if sequential gross margin fails to improve as internal InP sourcing scales or if guidance/order coverage is cut.
• Do not capitalize the $20 billion LTA as contracted near-term sales. Verify purchase minimums, cancellation provisions, customer prepayments, and shipment milestones in company filings; treat any deterioration as a thesis alert, not a confirmed revenue miss.
• Relative-value watch: compare COHR with Lumentum Holdings Inc. as optical demand broadens, but do not short the peer solely on Coherent’s results. Require evidence of share gains, margin divergence, and valuation support before establishing a pair.
• Track next-quarter capex versus operating cash flow, 6-inch InP yields and utilization, and PhotonLink shipment cadence. Rising investment without improved margins or funded customer commitments would weaken the risk/reward and argue for reducing exposure.